Postpartum, Pregnant
Conditions
Brief summary
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
Detailed description
The foundation for cardiovascular health (CVH) is laid in early life by intergenerational interactions, passed from parent to child, that have long-lasting biological and behavioral consequences. Lifestyle interventions can promote CVH among mothers and their children over time. Academic partnerships with home visiting organizations that reach families experiencing health disparities advance intergenerational CVH equity. For this pilot study we are testing the feasibility of doing remote data collection with a point of care device that measures HbA1c to use in the main study.
Interventions
After consent the participant will meet with the research team virtually to obtain HbA1c. The HbA1c self check equipment will be sent to the participant. During the video call the research team will talk the participant through obtaining their HbA1c with the point of care device.
Sponsors
Study design
Eligibility
Inclusion criteria
* English speaking * Screened or participating in NCT04253977 * Able to give informed consent for participation
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility to Obtain HbA1c Through Remote Data Collection | Baseline | Feasibility will be measured by how many participants are able to obtain HbA1c measure through remote data collection and participant's satisfaction with this means of data collection. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Point of Care Device Test the feasibility of doing remote data collection with a point of care device that measures HbA1c. | 18 |
| Total | 18 |
Baseline characteristics
| Characteristic | Point of Care Device |
|---|---|
| Age, Continuous | 30 Years |
| Ethnicity (NIH/OMB) Hispanic or Latino | 3 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 15 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 1 Participants |
| Race (NIH/OMB) Black or African American | 6 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 2 Participants |
| Race (NIH/OMB) White | 9 Participants |
| Sex: Female, Male Female | 18 Participants |
| Sex: Female, Male Male | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 18 |
| other Total, other adverse events | 0 / 18 |
| serious Total, serious adverse events | 0 / 18 |
Outcome results
Feasibility to Obtain HbA1c Through Remote Data Collection
Feasibility will be measured by how many participants are able to obtain HbA1c measure through remote data collection and participant's satisfaction with this means of data collection.
Time frame: Baseline
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Point of Care Device | Feasibility to Obtain HbA1c Through Remote Data Collection | Able to use point of care device | 17 Participants |
| Point of Care Device | Feasibility to Obtain HbA1c Through Remote Data Collection | Agreed or strongly agreed instructions were helpful | 16 Participants |